US 11028153
Targeting immunological functions to the site of bacterial infections using cell wall targeting domains of bacteriolysins
granted A61KA61K38/00A61P
Quick answer
US patent 11028153 (Targeting immunological functions to the site of bacterial infections using cell wall targeting domains of bacteriolysins) held by INTEGRATED BIOTHERAPEUTICS, INC. expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- INTEGRATED BIOTHERAPEUTICS, INC.
- Grant date
- Tue Jun 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K38/00, A61P, A61P11/00, A61P31/04